Roivant Sciences Ltd.(ROIV)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
ROIV | 25.22 B | - | -33.50% | 0.00% | -$0.53 | -8.52% | 0.02x | 0.00% | $42.50 | $17.28 |
GNS.L | 145.77 B | 523.29x | -4.10% | 43.35% | $4.25 | 45.88% | 0.14x | 0.02% | $3219.87 | $1943.00 |
KNSA | 4.02 B | 84.01x | 55.40% | 9.59% | $0.99 | 14.04% | 0.01x | 0.00% | $82.98 | $35.20 |
CMPS | 1.65 B | - | - | 0.00% | -$3.76 | -319.07% | 0.65x | 0.00% | $15.87 | $4.88 |
CNTA | - | - | - | - | - | - | - | - | - | - |
Peer Valuation & Performance Analysis
Peer group analysis for Roivant Sciences Ltd. (ROIV) compared to its primary competitors (including GNS.L, KNSA, CMPS) reveals distinct metrics. ROIV trades at a valuation discount relative to its competitors, with a P/E ratio of -65.9x versus the peer average of 201.4x (representing a 133% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, ROIV's revenue growth of -33.5% lags behind the peer average of 25.7%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 0.0% is below the peer average of 17.6%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• ROIV ranks #0 in P/E ratio, #3 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-21 | $37.94 | $38.37 | $35.99 | $36.80 | 16,839,635 | +5.38% |
| 2026-10-20 | $35.00 | $35.52 | $34.38 | $34.92 | 3,670,500 | +0.63% |
| 2026-10-19 | $33.78 | $35.14 | $33.60 | $34.70 | 6,334,300 | +3.49% |
| 2026-10-16 | $34.12 | $34.12 | $33.23 | $33.53 | 4,923,400 | -1.50% |
| 2026-10-15 | $33.82 | $34.35 | $33.70 | $34.04 | 4,565,900 | +1.25% |
| 2026-10-14 | $33.14 | $34.09 | $33.00 | $33.62 | 4,293,700 | +0.81% |
| 2026-10-13 | $34.44 | $34.91 | $33.26 | $33.35 | 6,322,200 | -3.58% |
| 2026-10-12 | $34.92 | $35.41 | $34.55 | $34.59 | 4,732,100 | -2.40% |
| 2026-10-09 | $34.24 | $35.59 | $34.15 | $35.44 | 5,533,200 | +3.60% |
| 2026-10-08 | $34.27 | $34.56 | $33.32 | $34.21 | 6,403,900 | -1.55% |
| 2026-10-07 | $35.22 | $35.48 | $34.63 | $34.75 | 5,738,800 | -2.20% |
| 2026-10-06 | $35.86 | $36.34 | $34.75 | $35.53 | 5,737,700 | -0.70% |
| 2026-10-05 | $35.98 | $36.33 | $35.24 | $35.78 | 6,200,500 | +0.17% |
| 2026-10-02 | $35.61 | $36.00 | $35.19 | $35.72 | 4,365,800 | +0.62% |
| 2026-10-01 | $36.35 | $36.79 | $35.44 | $35.50 | 3,272,000 | -2.93% |
Explore More Analysis for ROIV
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.